Melanoma News and reporting on melanoma. Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions. Castle Biosciences Awarded VA Supply Contract for Melanoma Test The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military. Germline Loss-of-Function Variants in ATM Gene May Contribute to Melanoma Predisposition Individuals with melanoma were more likely than controls to harbor loss-of-function variants or VUS, according to a newly published study. Integrated Tumor, Microbiome Features Influence Immunotherapy Combo Effects in Advanced Melanoma Gut microbiome features showed ties to treatment response and immune-related adverse events in advanced melanoma patients on a combined checkpoint blockade treatment. Astronomy, Biology Come Together for Cancer Biomarker Discovery Premium Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens. May 14, 2021 DermTech Q1 Revenues up 62 Percent May 10, 2021 Castle Biosciences Q1 Revenues Up 31 Percent Mar 8, 2021 Castle Biosciences Q4 Revenues Down 2 Percent Feb 16, 2021 Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases Jan 28, 2021 DermTech Using $144M Financing to Spur Marketing, Telemedicine Efforts For Molecular Melanoma Assay Premium Jan 22, 2021 Oppenheimer Initiates Coverage of DermTech With Outperform Rating Jan 19, 2021 OncoHost Raises $8 Million in Series B Funding Round Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Dec 14, 2020 Craig-Hallum Initiates Coverage of DermTech With Buy Rating Dec 10, 2020 Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Nov 18, 2020 IsoPlexis Targets New Market Segments With Cheaper, More Flexible Single-Cell Proteomic Systems Premium Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Nov 9, 2020 Castle Biosciences Q3 Revenues Up 3 Percent Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Oct 23, 2020 Melanoma Treatment Stage Affects Ability of Liquid Biopsy to Predict Immunotherapy Benefit Premium Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 7, 2020 Post-mortem Melanocyte Mutations Provide Melanoma Clues Sep 23, 2020 Pale Melanoma Susceptibility Linked to Albinism-Related Genes Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.